Chugai Pharmaceutical CoCHGCY +0.13%92 Dividend Yield % is 3.85% as of Jun. 24, 2026, which is 196% above its 10-year median of 1.30. GuruFocus rates CHGCY with a GF Score™ of 92/100 and a GF Value™ of $24.28 (Fairly Valued). The stock has 1 warning sign investors should review. Among 515 Drug Manufacturers companies, Chugai Pharmaceutical Co ranks worse than 57.48% on this metric.
As of today (2026-06-24), the Trailing Annual Dividend Yield of Chugai Pharmaceutical Co is 3.85%.
Good Sign:
Chugai Pharmaceutical Co Ltd stock Dividend Yield % is close to 2-year high.
The historical rank and industry rank for Chugai Pharmaceutical Co's Dividend Yield % or its related term are showing as below:
CHGCY'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.55 Med: 1.3 Max: 3.93
Current: 3.85
During the past 13 years, the highest Dividend Yield of Chugai Pharmaceutical Co was 3.93%. The lowest was 0.55%. And the median was 1.30%.
CHGCY's Dividend Yield % is ranked worse than 57.48% of 515
companies
in the Drug Manufacturers industry
Industry Median: 2.02
vs CHGCY: 3.85
During the past 12 months, Chugai Pharmaceutical Co's average Dividends Per Share Growth Rate was 24.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 16.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 16.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 24.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Chugai Pharmaceutical Co was 46.80% per year. The lowest was 0.00% per year. And the median was 10.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Chugai Pharmaceutical Co (OTCPK:CHGCY) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHGCY vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chugai Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Chugai Pharmaceutical Co's Dividend Yield % falls into.
Chugai Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Chugai Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.459852
2025-12-31
2025-12-31
2026-04-10
Cash Dividend
semi-annually
USD:USD 1.000000
USD 0.425167
2025-06-30
2025-06-30
2025-09-12
Cash Dividend
semi-annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chugai Pharmaceutical Co (CHGCY) has a Dividend Yield % of 3.85% as of Jun. 24, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Chugai Pharmaceutical Co and its competitors. This is 196% above median its historical median of 1.30. Over the past decade, Chugai Pharmaceutical Co's Dividend Yield % has ranged from 0.55 to 3.93. According to the industry distribution chart, Chugai Pharmaceutical Co ranks #296 out of 515 companies in the Drug Manufacturers industry, placing it in the top 57.5%.
Is Chugai Pharmaceutical Co's Dividend Yield % too high?
Chugai Pharmaceutical Co's current Dividend Yield % of 3.85% is 196% above median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 3.93. The Drug Manufacturers industry median Dividend Yield % is 2.02. Chugai Pharmaceutical Co's value of 3.85% is 90.6% above this industry median. Based on the distribution chart, Chugai Pharmaceutical Co ranks #296 out of 515 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Chugai Pharmaceutical Co has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Chugai Pharmaceutical Co ranks #296 out of 515 companies for Dividend Yield %. This places Chugai Pharmaceutical Co in the lower half of its industry. The industry median Dividend Yield % is 2.02. Chugai Pharmaceutical Co's value of 3.85% is 90.6% above this benchmark. Historically, Chugai Pharmaceutical Co's own Dividend Yield % has ranged from 0.55 to 3.93 over the past decade. While the company's 10-year median is 1.30 vs. the industry median of 2.02, Chugai Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.02, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chugai Pharmaceutical Co's current Dividend Yield % of 3.85% is 90.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Chugai Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chugai Pharmaceutical Co's current Dividend Yield % is 3.85%, which is 196% above median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Chugai Pharmaceutical Co (CHGCY) is currently considered Fairly Valued. The stock's GF Value™ is $24.28, compared to a current price of $22.99 — trading 5.3% below its estimated fair value. The current Dividend Yield % is 3.85%, which is 196% above median its 10-year median of 1.30 and 90.6% above the Drug Manufacturers industry median of 2.02. Chugai Pharmaceutical Co's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Chugai Pharmaceutical Co (CHGCY), the current Dividend Yield % is 3.85% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chugai Pharmaceutical Co (CHGCY) Overvalued in 2026?
Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued.
The current stock price of $22.99 is trading 5.3% below its estimated GF Value™ of $24.28.
GuruFocus considers Chugai Pharmaceutical Co to be Fairly Valued.
Key valuation signals for CHGCY:
Dividend Yield %: 3.85% (196% above median its 10-year median of 1.30)
GF Value™: $24.28 vs. price of $22.99 (5.3% below fair value)
Industry Position: 90.6% above the Drug Manufacturers median (#296 of 515)
No single metric tells the full story. See the CHGCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
92GF Score
Get the complete analysis for CHGCY
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHGCY has been successfully added to your 
